Delinking CARD9 and IL-17: CARD9 protects against Candida tropicalis infection through a TNF-α-dependent, IL-17-independent mechanism

Journal of Immunology

Volumn 195, Issue 8, 2015, Pages 3781-3792

  Whibley, Natasha ^a   Jaycox, Jillian R ^b   Reid, Delyth ^c   Garg, Abhishek V ^a   Taylor, Julie A ^c   Clancy, Cornelius J ^a   Nguyen, M Hong ^a   Biswas, Partha S ^a   McGeachy, Mandy J ^a   Brown, Gordon D ^c   Gaffen, Sarah L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CARNEGIE MELLON UNIVERSITY   (United States)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARD9 PROTEIN; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 23P19; REGULATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CARD9 PROTEIN, MOUSE; CASPASE RECRUITMENT DOMAIN SIGNALING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANDIDA TROPICALIS; CANDIDIASIS; CELL EXPANSION; CELL MIGRATION; CONTROLLED STUDY; INFECTION SENSITIVITY; MONOCYTE; MORTALITY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; PATHOLOGY;

ANIMALS; CANDIDA TROPICALIS; CANDIDIASIS; CARD SIGNALING ADAPTOR PROTEINS; INTERLEUKIN-17; MICE; MICE, KNOCKOUT; MONOCYTES; NEUTROPHILS; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84941732206     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500870     Document Type: Article

References (76)

1. Brown, G. D., D. W. Denning, N. A. Gow, S. M. Levitz, M. G. Netea, and T. C. White. 2012. Hidden killers: human fungal infections. Sci. Transl. Med. 4:165rv13.
2. Pfaller, M. A., and D. J. Diekema. 2010. Epidemiology of invasive mycoses in North America. Crit. Rev. Microbiol. 36:1-53.
3. Cassone, A. 2013. Development of vaccines for Candida albicans: fighting a skilled transformer. Nat. Rev. Microbiol. 11:884-891.
4. Plato, A., J. A. Willment, and G. D. Brown. 2013. C-type lectin-like receptors of the dectin-1 cluster: ligands and signaling pathways. Int. Rev. Immunol. 32:134-156.
5. Hardison, S. E., and G. D. Brown. 2012. C-type lectin receptors orchestrate antifungal immunity. Nat. Immunol. 13:817-822.
6. Gross, O., A. Gewies, K. Finger, M. Schäfer, T. Sparwasser, C. Peschel, I. Förster, and J. Ruland. 2006. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 442:651-656.
7. Glocker, E. O., A. Hennigs, M. Nabavi, A. A. Schäffer, C. Woellner, U. Salzer, D. Pfeifer, H. Veelken, K. Warnatz, F. Tahami, et al. 2009. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N. Engl. J. Med. 361:1727-1735.
8. Gavino, C., A. Cotter, D. Lichtenstein, D. Lejtenyi, C. Fortin, C. Legault, N. Alirezaie, J. Majewski, D. C. Sheppard, M. A. Behr, et al. 2014. CARD9 deficiency and spontaneous central nervous system candidiasis: complete clinical remission with GM-CSF therapy. Clin. Infect. Dis. 59:81-84.
9. Lanternier, F., S. A. Mahdaviani, E. Barbati, H. Chaussade, Y. Koumar, R. Levy, B. Denis, A. S. Brunel, S. Martin, M. Loop, et al. 2015. Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species-induced meningoencephalitis, colitis, or both. J. Allergy Clin. Immunol. 135:1558-1568.e2.
10. Dorhoi, A., C. Desel, V. Yeremeev, L. Pradl, V. Brinkmann, H. J. Mollenkopf, K. Hanke, O. Gross, J. Ruland, and S. H. Kaufmann. 2010. The adaptor molecule CARD9 is essential for tuberculosis control. J. Exp. Med. 207:777-792.
11. Hsu, Y. M., Y. Zhang, Y. You, D. Wang, H. Li, O. Duramad, X. F. Qin, C. Dong, and X. Lin. 2007. The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens. Nat. Immunol. 8:198-205.
12. Roth, S., and J. Ruland. 2013. Caspase recruitment domain-containing protein 9 signaling in innate immunity and inflammation. Trends Immunol. 34:243-250.
13. LeibundGut-Landmann, S., O. Gross, M. J. Robinson, F. Osorio, E. C. Slack, S. V. Tsoni, E. Schweighoffer, V. Tybulewicz, G. D. Brown, J. Ruland, and C. Reis e Sousa. 2007. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8:630-638.
14. van de Veerdonk, F. L., B. J. Kullberg, I. C. Verschueren, T. Hendriks, J. W. van der Meer, L. A. Joosten, and M. G. Netea. 2010. Differential effects of IL-17 pathway in disseminated candidiasis and zymosan-induced multiple organ failure. Shock 34:407-411.
15. Huang, W., L. Na, P. L. Fidel, and P. Schwarzenberger. 2004. Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J. Infect. Dis. 190:624-631.
16. Bär, E., P. G. Whitney, K. Moor, C. Reis e Sousa, and S. LeibundGut-Landmann. 2014. IL-17 regulates systemic fungal immunity by controlling the functional competence of NK cells. Immunity 40:117-127.
17. Saijo, S., S. Ikeda, K. Yamabe, S. Kakuta, H. Ishigame, A. Akitsu, N. Fujikado, T. Kusaka, S. Kubo, S. H. Chung, et al. 2010. Dectin-2 recognition of alphamannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 32:681-691.
18. Wu, W., Y. M. Hsu, L. Bi, Z. Songyang, and X. Lin. 2009. CARD9 facilitates microbe-elicited production of reactive oxygen species by regulating the LyGDIRac1 complex. Nat. Immunol. 10:1208-1214.
19. Gazendam, R. P., J. L. van Hamme, A. T. Tool, M. van Houdt, P. J. Verkuijlen, M. Herbst, J. G. Liese, F. L. van de Veerdonk, D. Roos, T. K. van den Berg, and T. W. Kuijpers. 2014. Two independent killing mechanisms of Candida albicans by human neutrophils: evidence from innate immunity defects. Blood 124:590-597.
20. Drewniak, A., R. P. Gazendam, A. T. Tool, M. van Houdt, M. H. Jansen, J. L. van Hamme, E. M. van Leeuwen, D. Roos, E. Scalais, C. de Beaufort, et al. 2013. Invasive fungal infection and impaired neutrophil killing in human CARD9 deficiency. Blood 121:2385-2392.
21. Guinea, J. 2014. Global trends in the distribution of Candida species causing candidemia. Clin. Microbiol. Infect. 20(Suppl. 6):5-10.
22. Krcmery, V., and A. J. Barnes. 2002. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance. J. Hosp. Infect. 50:243-260.
23. Dimopoulos, G., F. Ntziora, G. Rachiotis, A. Armaganidis, and M. E. Falagas. 2008. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome. Anesth. Analg. 106:523-529 (table of contents).
24. Li, W., Y. A. Hu, F. Q. Li, L. N. Shi, H. F. Shao, M. Huang, Y. Wang, D. D. Han, H. Liao, C. F. Ma, and G. Y. Zhang. 2015. Distribution of yeast isolates from invasive infections and their in vitro susceptibility to antifungal agents: evidence from 299 cases in a 3-Year (2010 to 2012) surveillance study. Mycopathologia 179:397-405.
25. Wingard, J. R., W. G. Merz, and R. Saral. 1979. Candida tropicalis: a major pathogen in immunocompromised patients. Ann. Intern. Med. 91:539-543.
26. Walsh, T. J., and W. G. Merz. 1986. Pathologic features in the human alimentary tract associated with invasiveness of Candida tropicalis. Am. J. Clin. Pathol. 85:498-502.
27. Kontoyiannis, D. P., I. Vaziri, H. A. Hanna, M. Boktour, J. Thornby, R. Hachem, G. P. Bodey, and I. I. Raad. 2001. Risk Factors for Candida tropicalis fungemia in patients with cancer. Clin. Infect. Dis. 33:1676-1681.
28. Wingard, J. R., J. D. Dick, W. G. Merz, G. R. Sandford, R. Saral, and W. H. Burns. 1980. Pathogenicity of Candida tropicalis and Candida albicans after gastrointestinal inoculation in mice. Infect. Immun. 29:808-813.
29. Fromtling, R. A., G. K. Abruzzo, and D. M. Giltinan. 1987. Candida tropicalis infection in normal, diabetic, and neutropenic mice. J. Clin. Microbiol. 25:1416-1420.
30. Butler, G., M. D. Rasmussen, M. F. Lin, M. A. Santos, S. Sakthikumar, C. A. Munro, E. Rheinbay, M. Grabherr, A. Forche, J. L. Reedy, et al. 2009. Evolution of pathogenicity and sexual reproduction in eight Candida genomes. Nature 459:657-662.
31. Odds, F. C. 1988. Candida and Candidosis. Elsevier Science Health Science Division, Ann Arbor, MI.
32. Martin, M. V. 1979. Germ-tube formation by oral strains of Candida tropicalis. J. Med. Microbiol. 12:187-193.
33. Zaugg, C., M. Borg-Von Zepelin, U. Reichard, D. Sanglard, and M. Monod. 2001. Secreted aspartic proteinase family of Candida tropicalis. Infect. Immun. 69:405-412.
34. Monod, M., S. Capoccia, B. Léchenne, C. Zaugg, M. Holdom, and O. Jousson. 2002. Secreted proteases from pathogenic fungi. Int. J. Med. Microbiol. 292:405-419.
35. Claudio, E., S. U. Sønder, S. Saret, G. Carvalho, T. R. Ramalingam, T. A. Wynn, A. Chariot, A. Garcia-Perganeda, A. Leonardi, A. Paun, et al. 2009. The adaptor protein CIKS/Act1 is essential for IL-25-mediated allergic airway inflammation. J. Immunol. 182:1617-1630.
36. Ifrim, D. C., J. M. Bain, D. M. Reid, M. Oosting, I. Verschueren, N. A. Gow, J. H. van Krieken, G. D. Brown, B. J. Kullberg, L. A. Joosten, et al. 2014. Role of Dectin-2 for host defense against systemic infection with Candida glabrata. Infect. Immun. 82:1064-1073.
37. Taylor, P. R., S. V. Tsoni, J. A. Willment, K. M. Dennehy, M. Rosas, H. Findon, K. Haynes, C. Steele, M. Botto, S. Gordon, and G. D. Brown. 2007. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat. Immunol. 8:31-38.
38. Pfaller, M. A., and D. J. Diekema. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20:133-163.
39. Drummond, R. A., and G. D. Brown. 2011. The role of Dectin-1 in the host defence against fungal infections. Curr. Opin. Microbiol. 14:392-399.
40. Fulurija, A., R. B. Ashman, and J. M. Papadimitriou. 1996. Neutrophil depletion increases susceptibility to systemic and vaginal candidiasis in mice, and reveals differences between brain and kidney in mechanisms of host resistance. Microbiology 142:3487-3496.
41. Ngo, L. Y., S. Kasahara, D. K. Kumasaka, S. E. Knoblaugh, A. Jhingran, and T. M. Hohl. 2014. Inflammatory monocytes mediate early and organ-specific innate defense during systemic candidiasis. J. Infect. Dis. 209:109-119.
42. Lionakis, M. S., M. Swamydas, B. G. Fischer, T. S. Plantinga, M. D. Johnson, M. Jaeger, N. M. Green, A. Masedunskas, R. Weigert, C. Mikelis, et al. 2013. CX3CR1-dependent renal macrophage survival promotes Candida control and host survival. J. Clin. Invest. 123:5035-5051.
43. Qian, Q., M. A. Jutila, N. Van Rooijen, and J. E. Cutler. 1994. Elimination of mouse splenic macrophages correlates with increased susceptibility to experimental disseminated candidiasis. J. Immunol. 152:5000-5008.
44. Huppler, A. R., H. R. Conti, N. Hernández-Santos, T. Darville, P. S. Biswas, and S. L. Gaffen. 2014. Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis. J. Immunol. 192:1745-1752.
45. Sunderkötter, C., T. Nikolic, M. J. Dillon, N. Van Rooijen, M. Stehling, D. A. Drevets, and P. J. Leenen. 2004. Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J. Immunol. 172:4410-4417.
46. van Rooijen, N., and E. Hendrikx. 2010. Liposomes for specific depletion of macrophages from organs and tissues. Methods Mol. Biol. 605:189-203.
47. Marino, M. W., A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, et al. 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94:8093-8098.
48. Louie, A., A. L. Baltch, R. P. Smith, M. A. Franke, W. J. Ritz, J. K. Singh, and M. A. Gordon. 1994. Tumor necrosis factor alpha has a protective role in a murine model of systemic candidiasis. Infect. Immun. 62:2761-2772.
49. Aggarwal, B. B., S. C. Gupta, and J. H. Kim. 2012. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey. Blood 119:651-665.
50. Lo, H. M., T. H. Lai, C. H. Li, and W. B. Wu. 2014. TNF-α induces CXCL1 chemokine expression and release in human vascular endothelial cells in vitro via two distinct signaling pathways. Acta Pharmacol. Sin. 35:339-350.
51. Ramesh, G., and W. B. Reeves. 2002. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J. Clin. Invest. 110:835-842.
52. Chang, M. S., J. McNinch, R. Basu, and S. Simonet. 1994. Cloning and characterization of the human neutrophil-activating peptide (ENA-78) gene. J. Biol. Chem. 269:25277-25282.
53. Griffith, J. W., C. L. Sokol, and A. D. Luster. 2014. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu. Rev. Immunol. 32:659-702.
54. Jhingran, A., K. B. Mar, D. K. Kumasaka, S. E. Knoblaugh, L. Y. Ngo, B. H. Segal, Y. Iwakura, C. A. Lowell, J. A. Hamerman, X. Lin, and T. M. Hohl. 2012. Tracing conidial fate and measuring host cell antifungal activity using a reporter of microbial viability in the lung. Cell Reports 2:1762-1773.
55. Jhingran, A., S. Kasahara, K. M. Shepardson, B. A. Junecko, L. J. Heung, D. K. Kumasaka, S. E. Knoblaugh, X. Lin, B. I. Kazmierczak, T. A. Reinhart, et al. 2015. Compartment-specific and sequential role of MyD88 and CARD9 in chemokine induction and innate defense during respiratory fungal infection. PLoS Pathog. 11:e1004589.
56. Ferrante, A. 1989. Tumor necrosis factor alpha potentiates neutrophil antimicrobial activity: increased fungicidal activity against Torulopsis glabrata and Candida albicans and associated increases in oxygen radical production and lysosomal enzyme release. Infect. Immun. 57:2115-2122.
57. Carmo, J. P., L. A. Dias-Melicio, S. A. Calvi, M. T. Peraçoli, and A. M. Soares. 2006. TNF-alpha activates human monocytes for Paracoccidioides brasiliensis killing by an H2O2-dependent mechanism. Med. Mycol. 44:363-368.
58. Ferrante, A., A. J. Martin, E. J. Bates, D. H. Goh, D. P. Harvey, D. Parsons, D. A. Rathjen, G. Russ, and J. M. Dayer. 1993. Killing of Staphylococcus aureus by tumor necrosis factor-alpha-activated neutrophils. The role of serum opsonins, integrin receptors, respiratory burst, and degranulation. J. Immunol. 151:4821-4828.
59. Netea, M. G., G. D. Brown, B. J. Kullberg, and N. A. Gow. 2008. An integrated model of the recognition of Candida albicans by the innate immune system. Nat. Rev. Microbiol. 6:67-78.
60. Hernández-Santos, N., and S. L. Gaffen. 2012. Th17 cells in immunity to Candida albicans. Cell Host Microbe 11:425-435.
61. Bishu, S., N. Hernández-Santos, M. R. Simpson-Abelson, A. R. Huppler, H. R. Conti, N. Ghilardi, A. J. Mamo, and S. L. Gaffen. 2014. The adaptor CARD9 is required for adaptive but not innate immunity to oral mucosal Candida albicans infections. Infect. Immun. 82:1173-1180.
62. Marakalala, M. J., S. Vautier, J. Potrykus, L. A. Walker, K. M. Shepardson, A. Hopke, H. M. Mora-Montes, A. Kerrigan, M. G. Netea, G. I. Murray, et al. 2013. Differential adaptation of Candida albicans in vivo modulates immune recognition by dectin-1. [Published erratum appears in 2013 PLos Pathog. 9: Available at: http://journals.plos.org/plospathogens/article?id=10.1371/annotation/7821bda1-dde3-4e72-b688-447b6bca20ea.]
63. PLoS Pathog. 9:e1003315. Available at: http://journals.plos.org/plospathogens/article?id=10.1371/journal.ppat.1003315.
64. Bär, E., A. Gladiator, S. Bastidas, B. Roschitzki, H. Acha-Orbea, A. Oxenius, and S. LeibundGut-Landmann. 2012. A novel Th cell epitope of Candida albicans mediates protection from fungal infection. J. Immunol. 188:5636-5643.
65. Iliev, I. D., V. A. Funari, K. D. Taylor, Q. Nguyen, C. N. Reyes, S. P. Strom, J. Brown, C. A. Becker, P. R. Fleshner, M. Dubinsky, et al. 2012. Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 336:1314-1317.
66. Robinson, M. J., F. Osorio, M. Rosas, R. P. Freitas, E. Schweighoffer, O. Gross, J. S. Verbeek, J. Ruland, V. Tybulewicz, G. D. Brown, et al. 2009. Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection. J. Exp. Med. 206:2037-2051.
67. Zhu, L. L., X. Q. Zhao, C. Jiang, Y. You, X. P. Chen, Y. Y. Jiang, X. M. Jia, and X. Lin. 2013. C-type lectin receptors Dectin-3 and Dectin-2 form a heterodimeric pattern-recognition receptor for host defense against fungal infection. Immunity 39:324-334.
68. Romani, L., A. Mencacci, E. Cenci, G. Del Sero, F. Bistoni, and P. Puccetti. 1997. An immunoregulatory role for neutrophils in CD4+ T helper subset selection in mice with candidiasis. J. Immunol. 158:2356-2362.
69. Morrell, M., V. J. Fraser, and M. H. Kollef. 2005. Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality. Antimicrob. Agents Chemother. 49:3640-3645.
70. Liang, P., X. Wang, R. Wang, Z. Wan, W. Han, and R. Li. 2015. CARD9 deficiencies linked to impaired neutrophil functions against Phialophora verrucosa. Mycopathologia 179:347-357.
71. Ermert, D., M. J. Niemiec, M. Rohm, A. Glenthoj, N. Borregaard, and C. F. Urban. 2013. Candida albicans escapes from mouse neutrophils. J. Leuk. Biol. 94:223-236.
72. Lindemann, R. A., and C. K. Franker. 1991. Phagocyte-mediated killing of Candida tropicalis. Mycopathologia 113:81-87.
73. Netea, M. G., L. J. van Tits, J. H. Curfs, F. Amiot, J. F. Meis, J. W. van der Meer, and B. J. Kullberg. 1999. Increased susceptibility of TNF-alpha lymphotoxinalpha double knockout mice to systemic candidiasis through impaired recruitment of neutrophils and phagocytosis of Candida albicans. J. Immunol. 163:1498-1505.
74. Ford, A. C., and L. Peyrin-Biroulet. 2013. Opportunistic infections with antitumor necrosis factor-a therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials. Am. J. Gastroenterol. 108:1268-1276.
75. Sanford, M., and K. McKeage. 2015. Secukinumab: first global approval. Drugs 75:329-338.
76. Langley, R. G., B. E. Elewski, M. Lebwohl, K. Reich, C. E. Griffiths, K. Papp, L. Puig, H. Nakagawa, L. Spelman, B. Sigurgeirsson, et al; ERASURE Study Group; FIXTURE Study Group. 2014. Secukinumab in plaque psoriasis-results of two phase 3 trials. N. Engl. J. Med. 371:326-338.